Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Angewandte Chemie (International Ed. in English)|January 29, 2013
BN/CC isosteric compounds as enzyme inhibitors: N- and B-ethyl-1,2-azaborine inhibit ethylbenzene hydroxylation as nonconvertible substrate analoguesDaniel H Knack, Jonathan L Marshall, Gregory P Harlow, et al.Cancer Research|May 1, 1991
Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomasS P Harlow, B L Eriksen, L Poggensee, et al.Journal of Cancer Research and Clinical Oncology|February 7, 2021
Diagnostic and management challenges for MDM2-, CDK4-negative fatty tumors of the retroperitoneumMax L Silverstein, Alexandra N Kalof, Kathryn C Kurchena, et al.Thrombosis Research|April 4, 1998
Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylationZ Y Zhang, J Kerr, R S Wexler, et al.The American Journal of Surgical Pathology|September 5, 2009
Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategyDonald L Weaver, Uyen Phuong Le, Stacey L Dupuis, et al.Archives of Otolaryngology--Head & Neck Surgery|March 4, 1998
Localization of regional lymph nodes in melanomas of the head and neckJ C Alex, D N Krag, S P Harlow, et al.Annals of Surgical Oncology|March 17, 2004
NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trialDavid N Krag, Thomas B Julian, Seth P Harlow, et al.Journal of the National Cancer Institute|August 26, 2009
Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trialDavid N Krag, Takamaru Ashikaga, Seth P Harlow, et al.Thrombosis Research|November 15, 1997
The characterization of potent novel warfarin analogsJ S Kerr, H Y Li, R S Wexler, et al.Cancer|October 7, 2006
Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance studyDonald L Weaver, David N Krag, Edward A Manna, et al.Pageof 6